Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
Henderson
I C
IC
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009378:Neoplasms, Multiple Primary / Q000209:etiology; D010166:Palliative Care; D016032:Randomized Controlled Trials as Topic; D011956:Receptors, Cell Surface / Q000032:analysis; D015996:Survival Rate; D013629:Tamoxifen / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011956:Receptors, Cell Surface; D013629:Tamoxifen